Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Katherine Wilemon"'
Autor:
Marina Cuchel, Paul C. Lee, Lisa C. Hudgins, P. Barton Duell, Zahid Ahmad, Seth J. Baum, MacRae F. Linton, Sarah D. de Ferranti, Christie M. Ballantyne, John A. Larry, Linda C. Hemphill, Iris Kindt, Samuel S. Gidding, Seth S. Martin, Patrick M. Moriarty, Paul P. Thompson, James A. Underberg, John R. Guyton, Rolf L. Andersen, David J. Whellan, Irwin Benuck, John P. Kane, Kelly Myers, William Howard, David Staszak, Allison Jamison, Mary C. Card, Mafalda Bourbon, Joana R. Chora, Daniel J. Rader, Joshua W. Knowles, Katherine Wilemon, Mary P. McGowan
Publikováno v:
Journal of the American Heart Association. 12
Background Homozygous familial hypercholesterolemia (HoFH) is a rare, treatment‐resistant disorder characterized by early‐onset atherosclerotic and aortic valvular cardiovascular disease if left untreated. Contemporary information on HoFH in the
Publikováno v:
Journal of the American College of Cardiology. 81:1231
Publikováno v:
Journal of Clinical Lipidology. 16:e36-e37
Autor:
P. Barton Duell, Dervilla McCann, Thomas Knickelbine, Matthew T. Roe, Catherine D. Ahmed, Iris Kindt, John Larry, Michael D. Shapiro, Linda C. Hemphill, Iftikhar J. Kullo, John R. Guyton, Seth S. Martin, Zahid Ahmad, Joshua W. Knowles, Lars Anderson, Samuel S. Gidding, Emily C. O'Brien, James A. Underberg, Eugenia Gianos, Daniel J. Rader, Patrick M. Moriarty, Marina Cuchel, Peter Shrader, Paul D. Thompson, Katherine Wilemon, MacRae F. Linton, Rolf Andersen
Publikováno v:
Atherosclerosis. 289:85-93
There are limited data from the US on outcomes of patients in specialty care for familial hypercholesterolemia (FH).CASCADE FH Registry data were analyzed to assess longitudinal changes in medication usage, in low density lipoprotein cholesterol (LDL
Autor:
Daniel Soffer, Samip Sheth, Archna Bajaj, Marjorie Risman, Douglas Jacoby, Daniel J. Rader, Jihane Hajj, Paul A. Lee, Yulia Borovskiy, Gayley Webb, Erik Hossain, Marina Cuchel, Katherine Wilemon, Kelly D. Myers
Publikováno v:
Circulation. Cardiovascular Quality and Outcomes
Publikováno v:
Curr Atheroscler Rep
PURPOSE OF REVIEW: To highlight the gender-based differences in presentation and disparities in care for women with familial hypercholesterolemia (FH). RECENT FINDINGS: Women with FH experience specific barriers to care including underrepresentation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9624a4de44d42b18e66d100b539c7a0
https://europepmc.org/articles/PMC7508565/
https://europepmc.org/articles/PMC7508565/
Autor:
Claudia Stefanutti, Myra Tilney, Mutaz Alkhnifsawi, Carlos A. Aguilar-Salinas, Jean-Luc Eiselé, Raul D. Santos, Pedro Mata, Gloria Hastings, Gerald F. Watts, Inge Schalkers, Sarah D. de Ferranti, Francesco Fuggetta, Daniel Soffer, Brian Tomlinson, Rodrigo Alonso, Tania Leme da Rocha Martinez, Rody G. Sy, Maria Cristina de Oliveira Izar, Atsushi Nohara, Ákos G Gesztes, Laura Schreier, Nanette K. Wenger, Aram Zegerius, Leiv Ose, Letrillart Marion, David Marais, André R. Miserez, Lina Badimon, Ian Hamilton-Craig, Martin Prøven Bogsrud, Roopa Mehta, Stephen J. Nicholls, Lale Tokgozoglu, Samuel S. Gidding, Amy L. Peterson, Mariko Harada-Shiba, Sue Koob, Jules Payne, Emanuela Folco, Raman Puri, Meral Kayıkçıoğlu, Martha L. Tamayo, Michael D. Shapiro, David S. Wald, Børge G. Nordestgaard, Inese Maurina, Kristyna Cillíková, Antonio J. Vallejo-Vaz, Gerardo Elikir, Masahiro Koseki, Diana Maxwell, Ashraf Reda, Gunnar N Karlsson, Jasmine Patel, Lynne T. Braun, Greizy López, Jing Pang, Marcos M. Lima-Martínez, Urh Groselj, G. Kees Hovingh, Kausik K. Ray, Stacey R. Lane, Eric J.G. Sijbrands, Darien Wood, I.M. Gaspar, Pablo Corral, Alberico L. Catapano, Alejandra Vázquez-Cárdenas, Khalid Al-Rasadi, Luz M Bernal, Allison Jamison, Wael Almahmeed, Catherine D. Ahmed, Joep C. Defesche, Olivier S. Descamps, Tomáš Freiberger, Athanasios Pallidis, Dermot Neely, Gabriele Hanauer-Mader, Tiziana Sampietro, Liam R. Brunham, Patrícia Vieira de Luca, Mario Stoll, Michaela Wolf, Monica P Popescu, Regina Cuevas, Thomas A. Gaziano, George A. Mensah, Katherine Wilemon
Publikováno v:
JAMA Cardiology, 5(2), 217-229. American Medical Association
Wilemon, K A, Patel, J, Aguilar-Salinas, C, Ahmed, C D, Alkhnifsawi, M, Almahmeed, W, Alonso, R, Al-Rasadi, K, Badimon, L, Bernal, L M, Bogsrud, M P, Braun, L T, Brunham, L, Catapano, A L, Čillíková, K, Corral, P, Cuevas, R, Defesche, J C, Descamps, O S, De Ferranti, S, Eiselé, J L, Elikir, G, Folco, E, Freiberger, T, Fuggetta, F, Gaspar, I M, Gesztes, Á G, Grošelj, U, Hamilton-Craig, I, Hanauer-Mader, G, Harada-Shiba, M, Hastings, G, Hovingh, G K, Izar, M C, Jamison, A, Karlsson, G N, Kayikçioǧlu, M, Koob, S, Koseki, M, Lane, S, Lima-Martinez, M M, López, G, Martinez, T L, Marais, D, Marion, L, Mata, P, Maurina, I, Maxwell, D, Mehta, R, Nordestgaard, B G & Global Familial Hypercholesterolemia Community 2020, ' Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia : A Global Call to Action ', JAMA Cardiology, vol. 5, no. 2, pp. 217-229 . https://doi.org/10.1001/jamacardio.2019.5173
Wilemon, K A, Patel, J, Aguilar-Salinas, C, Ahmed, C D, Alkhnifsawi, M, Almahmeed, W, Alonso, R, Al-Rasadi, K, Badimon, L, Bernal, L M, Bogsrud, M P, Braun, L T, Brunham, L, Catapano, A L, Čillíková, K, Corral, P, Cuevas, R, Defesche, J C, Descamps, O S, De Ferranti, S, Eiselé, J L, Elikir, G, Folco, E, Freiberger, T, Fuggetta, F, Gaspar, I M, Gesztes, Á G, Grošelj, U, Hamilton-Craig, I, Hanauer-Mader, G, Harada-Shiba, M, Hastings, G, Hovingh, G K, Izar, M C, Jamison, A, Karlsson, G N, Kayikçioǧlu, M, Koob, S, Koseki, M, Lane, S, Lima-Martinez, M M, López, G, Martinez, T L, Marais, D, Marion, L, Mata, P, Maurina, I, Maxwell, D, Mehta, R, Nordestgaard, B G & Global Familial Hypercholesterolemia Community 2020, ' Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia : A Global Call to Action ', JAMA Cardiology, vol. 5, no. 2, pp. 217-229 . https://doi.org/10.1001/jamacardio.2019.5173
ImportanceFamilial hypercholesterolemia (FH) is an underdiagnosed and undertreated genetic disorder that leads to premature morbidity and mortality due to atherosclerotic cardiovascular disease. Familial hypercholesterolemia affects 1 in 200 to 250 p
Autor:
Peter P. Toth, James A. Underberg, Seth J. Baum, Joyce L. Ross, Paul S. Jellinger, Katherine Wilemon
Publikováno v:
Clinical Cardiology
The proprotein convertase subtilisin/kexin type 9 inhibitors or monoclonal antibodies likely represent the greatest advance in lipid management in 30 years. In 2015 the US Food and Drug Administration approved both alirocumab and evolocumab for high-
Publikováno v:
Journal of the American College of Cardiology. 74:2951-2952
Webster et al. ([1][1]) published a clinical series in the Journal recording their experience with identification of inherited cardiovascular disorders in a cohort of children referred for family history of sudden death; however, they neglected to ev
Autor:
Niloofar Farboodi, Samuel S. Gidding, Kelly D. Myers, David Staszak, Daniel J. Rader, Mkaya Mwamburi, Seth J. Baum, Katherine Wilemon, William Howard
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 12
Background: Atherosclerotic cardiovascular disease remains a major cause of death and disability, especially for high-risk familial hypercholesterolemia individuals. PCSK9i (proprotein convertase subtilisin kexin type 9 inhibitors) reduce low-density